Janssen Biotech to buy HC2 Holdings subsidiary

HC2 Holdings Inc. (NYSE: HCHC) subsidiary BeneVir Biopharma will be acquired by Janssen Biotech. The stock price soared $1.79 to close at $6.96.


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.